PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
26-Sep-2025 Hovione and Microinnova partner to advance modular flow chemistry for multi-purpose manufacturing Hovione
26-Sep-2025 Aesthetic Surgery Center Wins First Place in Three Categories in the 2025 Best of Naples Community's Choice Awards ACCESS Newswire
26-Sep-2025 Exousia Pro Reports Positive Outcome in Legal Proceeding ACCESS Newswire
26-Sep-2025 CASI Pharmaceuticals Appoints James Huang to Board of Directors ACCESS Newswire
26-Sep-2025 Medical Care Technologies Inc. Introduces AI-Powered Facial Analysis for Diabetic Retinopathy Detection ACCESS Newswire
26-Sep-2025 enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment ACCESS Newswire
26-Sep-2025 Concept Life Sciences Expands Integrated Drug Discovery Facilities Concept Life Sciences
26-Sep-2025 African Leaders Call for Bold, United Action to Tackle Global Health Crises and Sustain Malaria Progress ACCESS Newswire
26-Sep-2025 Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial (news with additional features) Pentixapharm Holding AG
25-Sep-2025 Mending Kids to Host 8th Annual Hike 2 Mend, a Free Community Walk Supporting Surgical Care for Children ACCESS Newswire
25-Sep-2025 Wellgistics Health Announces Pricing of $5 Million Public Offering ACCESS Newswire
25-Sep-2025 OPEN Healthcare Celebrates Grand Opening of 23,000 Sq. Ft. Innovative Diagnostic Laboratory and Launch of At-Home Testing Service in Gardena, California ACCESS Newswire
25-Sep-2025 ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer ACCESS Newswire
25-Sep-2025 Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 ACCESS Newswire
25-Sep-2025 MMJ's FDA Cannabis Softgel Capsule Could Be the Real Game Changer for Huntington's - Gene Therapy Sparks Hope ACCESS Newswire
25-Sep-2025 Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine AC Immune SA
25-Sep-2025 Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma Heidelberg Pharma AG
25-Sep-2025 Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis Immunic AG
25-Sep-2025 Primum Health Raises Seed Round Led by FCA Venture Partners and North Coast Ventures ACCESS Newswire
25-Sep-2025 New State-of-the-Art Liverpool Facility Set to Supercharge Northern Arc Growth – Powering the Economy and Creating Jobs BioGrad